Mettler-Toledo International (NYSE:MTD) Price Target Raised to $1,210.00 at Robert W. Baird

Key Points

• Investment analysts at Robert W. Baird raised the price target for Mettler-Toledo International from $1,139.00 to $1,210.00, maintaining a "neutral" rating.
• Mettler-Toledo's stock has an average rating of "Hold" from 12 analysts, with an average price target of $1,298.50.
• Despite recent price target adjustments, the stock reflects a potential downside of 4.66% from its current price of about $1,269.12.

Mettler-Toledo International (NYSE:MTD - Get Free Report) had its price target lifted by investment analysts at Robert W. Baird from $1,139.00 to $1,210.00 in a research report issued on Monday,Benzinga reports. The brokerage presently has a "neutral" rating on the medical instruments supplier's stock. Robert W. Baird's price objective would indicate a potential downside of 4.66% from the company's current price.

A number of other equities research analysts have also commented on MTD. UBS Group raised shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and decreased their price objective for the stock from $1,530.00 to $1,350.00 in a report on Tuesday, May 20th. Wall Street Zen lowered shares of Mettler-Toledo International from a "buy" rating to a "hold" rating in a research note on Monday, May 5th. Bank of America raised their target price on shares of Mettler-Toledo International from $1,200.00 to $1,260.00 and gave the company a "neutral" rating in a research note on Thursday, June 26th. Evercore ISI increased their price target on shares of Mettler-Toledo International from $1,200.00 to $1,280.00 and gave the company an "outperform" rating in a research report on Tuesday, July 8th. Finally, Wells Fargo & Company lifted their price objective on shares of Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the stock an "equal weight" rating in a research note on Monday, May 5th. Seven analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat, Mettler-Toledo International has an average rating of "Hold" and an average price target of $1,298.50.

Mettler-Toledo International Price Performance

Shares of MTD traded up $5.13 during trading hours on Monday, hitting $1,269.12. The stock had a trading volume of 19,556 shares, compared to its average volume of 174,121. The company's fifty day moving average is $1,183.68 and its two-hundred day moving average is $1,193.28. Mettler-Toledo International has a 52 week low of $946.69 and a 52 week high of $1,546.93. The stock has a market capitalization of $26.37 billion, a price-to-earnings ratio of 31.58, a P/E/G ratio of 3.89 and a beta of 1.37.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last issued its quarterly earnings data on Thursday, May 1st. The medical instruments supplier reported $8.19 EPS for the quarter, topping analysts' consensus estimates of $7.90 by $0.29. Mettler-Toledo International had a net margin of 22.17% and a negative return on equity of 556.22%. The firm had revenue of $883.74 million for the quarter, compared to analyst estimates of $876.61 million. During the same quarter in the prior year, the firm earned $8.89 EPS. The company's revenue was down 4.6% on a year-over-year basis. Equities analysts predict that Mettler-Toledo International will post 42.71 EPS for the current fiscal year.

Insider Activity

In other news, Director Michael A. Kelly sold 1,062 shares of Mettler-Toledo International stock in a transaction that occurred on Wednesday, May 28th. The shares were sold at an average price of $1,159.93, for a total value of $1,231,845.66. Following the sale, the director directly owned 120 shares in the company, valued at $139,191.60. This trade represents a 89.85% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 0.77% of the stock is owned by company insiders.

Institutional Trading of Mettler-Toledo International

Hedge funds and other institutional investors have recently made changes to their positions in the business. Verdence Capital Advisors LLC grew its stake in shares of Mettler-Toledo International by 8.7% in the second quarter. Verdence Capital Advisors LLC now owns 438 shares of the medical instruments supplier's stock valued at $515,000 after buying an additional 35 shares in the last quarter. MGO One Seven LLC bought a new position in shares of Mettler-Toledo International in the second quarter valued at $204,000. Index Fund Advisors Inc. bought a new position in shares of Mettler-Toledo International in the second quarter valued at $203,000. M3 Advisory Group LLC bought a new position in Mettler-Toledo International during the second quarter worth $210,000. Finally, CWM LLC boosted its position in Mettler-Toledo International by 32.1% during the second quarter. CWM LLC now owns 868 shares of the medical instruments supplier's stock worth $1,020,000 after purchasing an additional 211 shares during the period. 95.07% of the stock is currently owned by institutional investors and hedge funds.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.